NCT00950170 - Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 10, 2010

Primary Completion Date

November 24, 2016

Study Completion Date

November 24, 2016

Conditions

Hemophilia A

Interventions

PROCEDURE

Laboratory Tests

Blood draws to determine the level of factor VIII activity before and after dosing at appropriate visits, and blood draws to determine levels of factor VIII inhibitor (antibody to factor VIII).

Trial Locations (11)

28046

Hospital Universitario La Paz, Madrid

28177

Klinikum Bremen-Mitte gGmbH, Professor Hess Kinderklinik, Bremen

30625

Medizinische Hochschule, Hannover, Hanover

34098

Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul

35100

Ege Universitesi Tip Fakultesi, Bornova

44093

CHU de Nantes, Nantes

46009

Hospital Universitario La Fe, Valencia

50134

Agenzia per L'emofilia e Centro Regionale Riferimento Coagulopatie Congenite, Florence

79044

"Derzhavna ustanova Instytut patolohii krovi ta transfuziinoi medytsyny Natsionalnoi akademii", Lviv

9713 GZ

University Medical Center Groningen, Groningen

01330

Cukurova Universitesi Tip Fakultesi, Adana